Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Ventyx Biosciences (Nasdaq: VTYX), a clinical-stage biopharmaceutical company developing novel oral therapies for inflammatory diseases, has announced its participation in two upcoming investor conferences:

1. 2024 Wells Fargo Healthcare Conference in Boston, MA on September 4, 2024, from 11:00-11:35 AM ET.

2. Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on September 6, 2024, from 1:05-1:40 PM ET.

Webcasts of the presentations will be available on the Ventyx website (www.ventyxbio.com) in the Investors and News section. Replays will be accessible for thirty days after the events.

News Market Reaction

-0.23%

1 alert

-0.23% News Effect

On the day this news was published, VTYX declined 0.23%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the following upcoming investor conferences:

• Event: 2024 Wells Fargo Healthcare Conference
  Location: Boston, MA
  Date: Wednesday, September 4, 2024
  Time: 11:00-11:35 AM ET

• Event: Morgan Stanley 22nd Annual Global Healthcare Conference
  Location: New York, NY
  Date: Friday, September 6, 2024
  Time: 1:05-1:40 PM ET

A webcast of the presentations will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days.

About Ventyx Biosciences

Ventyx is a clinical-stage biopharmaceutical company focused on advancing novel oral therapies for patients living with inflammatory diseases. We believe our ability to efficiently discover and develop differentiated drug candidates will allow us to address important unmet medical need with novel oral therapies that can shift inflammation markets from injectable to oral drugs. Our current pipeline includes internally discovered clinical programs targeting NLRP3, S1P1R and TYK2, positioning us to become a leader in the development of oral therapies for peripheral and neuroinflammatory diseases. Ventyx is headquartered in San Diego, California. For more information about Ventyx, please visit www.ventyxbio.com.

Investor Relations Contact
Patti Bank
Managing Director
ICR Westwicke
(415) 513-1284
IR@ventyxbio.com

FAQ

When is Ventyx Biosciences (VTYX) presenting at the Wells Fargo Healthcare Conference in 2024?

Ventyx Biosciences (VTYX) is presenting at the Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, from 11:00-11:35 AM ET in Boston, MA.

What is the date and time of Ventyx Biosciences' (VTYX) presentation at the Morgan Stanley Global Healthcare Conference in 2024?

Ventyx Biosciences (VTYX) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, September 6, 2024, from 1:05-1:40 PM ET in New York, NY.

How can investors access the webcasts of Ventyx Biosciences' (VTYX) presentations at the upcoming conferences?

Investors can access the webcasts of Ventyx Biosciences' (VTYX) presentations in the Investors and News section of the company's website at www.ventyxbio.com.

How long will the replays of Ventyx Biosciences' (VTYX) conference presentations be available?

Replays of Ventyx Biosciences' (VTYX) conference presentations will be available on the company's website for thirty days after the conclusion of each event.